59468-84-7

Usage

Uses

Used in Pharmaceutical Industry:
4-ACETOXY-8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE is used as an intermediate in the synthesis of CYP3A4, a metabolite of Midazolam. This application is significant because it contributes to the development of new drugs and the understanding of drug metabolism.
Used in Metabolite Research:
In the field of pharmaceutical research, 4-ACETOXY-8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE is also recognized as a metabolite of Midazolam (M343000). Its study helps researchers understand the metabolic pathways of drugs and their potential effects on the human body.
Chemical Properties:
4-ACETOXY-8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE is described as a brown solid, which is an important characteristic for its identification and handling in various applications.

Upstream product

• 108-24-7 acetic anhydride 
• 59468-83-6 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine 5-oxide 
• 59469-30-6 1-acetyl-2-(acetylamino-methyl)-7-chloro-5-(2-fluoro-phenyl)-2,3-dihydro-1H-benzo[e][1,4]diazepine 
• 59467-64-0 (7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-2-yl)methanamine 
• 59467-70-8 Midazolam 

Downstream Products

• 59468-85-8 4-hydroxymidazolam 

Relevant academic research and scientific papers

Impurity A and impurity B of midazolam or pharmaceutical composition thereof and application thereof

The invention belongs to the field of medical chemistry, and particularly relates to an impurity A and an impurity B of midazolam or a pharmaceutical composition of midazolam and a preparation methodthereof, and application of the impurity A and the impur

Imidazodiazepines and processes therefor

Novel Imidazobenzodiazepines and their analogs are useful as anticonvulsants, muscle relaxant, anxiolytic and sedative agents. Preferred compounds of this class belong to the imidazo[1,5-a][1,4]diazepine series which may have a very wide variety of organic substituents. An especially preferred genus included within the purview of the invention encompasses a compound of the formula STR1 wherein R1 is hydrogen and lower alkyl preferably methyl; R3 and R5 are hydrogen; R4 is hydrogen, nitro and halogen, most preferably, chlorine, and in a most preferred embodiment when positioned on the fused benzo portion of the imidazobenzodiazepine is in the 8-position thereof, R6 is phenyl or halo, nitro, or lower alkyl-substituted phenyl, preferably, halo, with fluorine being the preferred halogen, the substituted fluoro being positioned in the 2-position of the phenyl moiety and R2 is hydrogen and lower alkyl.